30,485 Shares in Encompass Health Corporation $EHC Bought by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio bought a new stake in Encompass Health Corporation (NYSE:EHCFree Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 30,485 shares of the company’s stock, valued at approximately $3,081,000.

Several other large investors also recently modified their holdings of the stock. Capstone Investment Advisors LLC acquired a new position in Encompass Health in the 2nd quarter worth about $345,000. Transamerica Financial Advisors LLC bought a new position in Encompass Health in the 2nd quarter valued at $29,000. Corient Private Wealth LP purchased a new stake in Encompass Health in the second quarter worth approximately $1,717,000. Bank of America Corp DE bought a new stake in shares of Encompass Health in the second quarter worth about $79,660,000. Finally, Freestone Grove Partners LP bought a new position in shares of Encompass Health in the 2nd quarter worth about $38,677,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Performance

NYSE:EHC opened at $121.80 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The company has a market cap of $12.02 billion, a P/E ratio of 19.84, a P/E/G ratio of 2.48 and a beta of 0.75. The firm’s 50 day moving average is $115.33 and its two-hundred day moving average is $107.58.

Encompass Health (NYSE:EHCGet Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same quarter last year, the firm posted $1.40 earnings per share. Encompass Health’s revenue for the quarter was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Analysts expect that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Thursday, October 1st. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. Encompass Health’s dividend payout ratio (DPR) is 12.38%.

Analyst Ratings Changes

EHC has been the subject of a number of research reports. Barclays upped their price objective on Encompass Health from $140.00 to $144.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. UBS Group boosted their target price on Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Truist Financial upped their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Weiss Ratings raised shares of Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 12th. Finally, TD Cowen boosted their target price on shares of Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $148.71.

Check Out Our Latest Analysis on Encompass Health

Insider Buying and Selling

In other news, CEO Mark J. Tarr sold 173,148 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the sale, the chief executive officer directly owned 267,814 shares in the company, valued at $33,602,622.58. This trade represents a 39.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP John Darby sold 4,858 shares of Encompass Health stock in a transaction on Monday, August 31st. The stock was sold at an average price of $121.09, for a total transaction of $588,255.22. Following the completion of the sale, the executive vice president owned 75,041 shares of the company’s stock, valued at approximately $9,086,714.69. This trade represents a 6.08% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 186,912 shares of company stock worth $23,434,845 in the last quarter. Insiders own 1.80% of the company’s stock.

About Encompass Health

(Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

Read More

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHCFree Report).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.